prolong the shelf life of foods. The antagonistic properties of LAB derive from competition for nutrients and the production of one or more antimicrobial active metabolites such as organic acids
food supply becomes critical due to the increased awareness among consumers and competitive nature of food industries, the demand for rapid, low volume and sensitive biosensor devices has dramatically increased
prolong the shelf life of foods. The antagonistic properties of LAB derive from competition for nutrients and the production of one or more antimicrobial active metabolites such as organic acids
formation and hence carbon sequestration under such nutrient starvation conditions could provide a competitive advantage to those bacteria capable of PHB and other polydroxyalkanoates accumulation, providing a…
realized along with biostimulation and bioaugmentation. The positive microbial activities include the competitive exclusion of pathogenic bacteria production of bactericidal substances as well as degradation of uneaten…
higher recovery and quality of oil than comparable crops, and has no direct competition for food crops as it is an edible source of fuel, with no direct competition with
SWNTs also possess high carrier mobility, and may have performance (conduction and transmission) properties competitive with conventional transparent conductors (e.g. indium tin oxide). Photovoltaic devices based on…
will be constantly adapting to the changing legal landscape in order to gain a competitive advantage. The America Invents Act (AIA) has introduced the most significant changes to patent
Biologics Price Competition and Innovation Act (BPCIA) provide an approval pathway for biosimilar products. Within the BPCIA, there is twelve year exclusivity for the originator/reference product. Whereby, the Food
patents. Trade secrets of the biosimilar manufacturer may be revealed to its most direct competition, as details of the biosimilar manufacturer?s own process may be revealed to the innovator
presented. In order to be attractive to the medical community and to be competitive in the market place, PEG-biosimilars must be safe, more potent, longer-acting and cost-effective
Congress, as part of the 2010 Health Care Reform legislation, enacted the Biologics Price Competition and Innovation Act (BPCIA), which created an abbreviated pathway for lower cost ?Biosimilar? versions
establishes the pathway will have a tremendous infl uence on the competitive impact of biosimilars in the market. Other factors that the FDA must take into account are clinical trials ... ecting the market are data…
biosimilar medicinal products by the European Medicine Agency (EMA) of the European Union (EU). Competition of cost-eff ective follow- on biological products with equivalent effi cacy and safety
biosimilar medicinal products by the European Medicine Agency (EMA) of the European Union (EU). Competition of cost-eff ective follow- on biological products with equivalent effi cacy and safety
with a consequent increase of the generic copies of these medications, creating greater product competition and consequently, price reduction. Bioequivalence studies for nasal sprays are still under discussion
placed in a high Schedule, will substantially impact on the drug?s market competitiveness and may also impair its distribution and be a barrier to prescribing. Th e mandatory abuse
will allow scientifically valid and more economical testing of generic drugs. This will increase competition, and significantly reduce the cost of generic drug products without increasing patient risk PDF HTML
method, i.e. a bilitranslocase-specific functional assay (3) in membrane vesicles where potential ligands (competitive and non-competitive inhibitors) are identified, yields data predictive of bilitranslocase function…
aqueous mucosal surface. Drug gets dissociated from the complex by simple dilution, competitive displacement, uptake of drug in tissues inaccessible to the cyclodextrins, binding of drug to plasma and tissue
leads to complicated formulations, regimens and delivery systems to increase the barrier to generic competition. One of the tools that can be used by generic formulators is dissolution testing
reduces the surplus available for R&D. Market exclusivity is shrinking due to competition. Recovery of investment made in R&D is difficult day by day. India has easy availability
produced using microbial fermentation process rather than chemical synthesis because the fermentations are economically competitive and produce biologically active isomers. To carry out further drug development work…
practice includes litigation and trial work in the areas of trademark, false advertising, unfair competition, copyright, as well as other types of business disputes. She joined Liner Grode Stein after
this study:1) Blocking GPVI with antibody fragments, and 2) Triggering a binding competition using a novel synthetic peptidomimetic. 1. Starting from a well-characterized hybridoma secreting an IgGk
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.